John W. Eklund practices Hematology. He went to medical school at University of Illinois College of Medicine. John Eklund is a published doctor. He published 9 publications, including: 'A pilot study of denileukin diftitox (DD) in combination with high-dose interleukin-2 (IL-2) for patients with metastatic renal cell carcinoma (RCC).' He is registered with Medicare and accepts Medicare payments.
NPI NUMBER | 1174510523 | |
NPPES Provider LastName | EKLUND | |
NPPES Provider FirstName | JOHN | |
NPPES Provider ZIPCode | 607145905 | |
NPPES Provider State | IL | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 912.0 | |
Distinct Opioid Count | 2.0 | |
Opioid Claim Count | 107.0 | |
Percent Opioid Claims | 11.73 |
National Provider Identifier [NPI] | 1174510523 |
Last Name Of The Provider | EKLUND |
First Name Of The Provider | JOHN |
View All |
![]() |
Dr. Lisa L. Baddi, MD
![]() |
![]() |
Dr. Leonard M. Klein, MD
![]() |
![]() |
Dr. Susan G. Brown, MD
![]() ![]() |
![]() |
Dr. David Hakimian, MD
![]() ![]() |
![]() |
Dr. Bruce R. Kaden, MD
![]() ![]() |
![]() |
Dr. Christopher G. Rose, MD |